| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Andrea Maugeri | Q59685246 |
| Massimiliano Veroux | Q38329953 | ||
| Martina Barchitta | Q41528621 | ||
| Antonella Agodi | Q43472502 | ||
| P2093 | author name string | Giulia Bernardini | |
| Daniela Corona | |||
| Guido Basile | |||
| Matilde Zamboni | |||
| P2860 | cites work | Resveratrol Modulates SIRT1 and DNMT Functions and Restores LINE-1 Methylation Levels in ARPE-19 Cells under Oxidative Stress and Inflammation | Q63977092 |
| Needle biopsy evaluation of class II major histocompatibility complex antigen expression for the differential diagnosis of cyclosporine nephrotoxicity from kidney graft rejection | Q68185318 | ||
| ESRD patients in 2001: global overview of patients, treatment modalities and development trends | Q78580461 | ||
| DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy | Q82848506 | ||
| Improving long-term outcomes for transplant patients: making the case for long-term disease-specific and multidisciplinary research | Q85013471 | ||
| A map of human genome variation from population-scale sequencing | Q24617794 | ||
| New loci associated with kidney function and chronic kidney disease | Q24630646 | ||
| DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis | Q26798393 | ||
| Treg functional stability and its responsiveness to the microenvironment | Q27008946 | ||
| Epigenomics: the science of no-longer-junk DNA. Why study it in chronic kidney disease? | Q27013782 | ||
| Epigenetics: a landscape takes shape | Q29616623 | ||
| Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? | Q44573200 | ||
| New opportunities for organ transplantation research: epigenetics is likely to be an important determinant of the host immune response | Q45382914 | ||
| Ischemia- reperfusion injury and its influence on the epigenetic modification of the donor kidney genome | Q46897225 | ||
| Adipose tissue DNA methylome changes in development of new-onset diabetes after kidney transplantation. | Q47920157 | ||
| Renal transplantation increases angiotensin II receptor-mediated vascular contractility associated with changes of epigenetic mechanisms. | Q49379899 | ||
| Epigenetic modification of the human CCR6 gene is associated with stable CCR6 expression in T cells. | Q51024074 | ||
| Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes. | Q53123771 | ||
| DNA Methyltransferases, DNA Methylation, and Age-Associated Cognitive Function. | Q53513671 | ||
| Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer. | Q55332434 | ||
| Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009 | Q56334541 | ||
| Chronic renal diseases as a public health problem: epidemiology, social, and economic implications | Q57702843 | ||
| Curcumin Modulates DNA Methyltransferase Functions in a Cellular Model of Diabetic Retinopathy | Q59447403 | ||
| Intragraft Regulatory T Cells in Protocol Biopsies Retain Foxp3 Demethylation and Are Protective Biomarkers for Kidney Graft Outcome | Q59491274 | ||
| Association of Caveolin-1 Gene Polymorphism With Kidney Transplant Fibrosis and Allograft Failure | Q60544423 | ||
| Age is an important predictor of kidney transplantation outcome | Q61756964 | ||
| Oxidative stress in kidney transplantation: malondialdehyde is an early predictive marker of graft dysfunction | Q61805983 | ||
| Worldwide patterns of human epigenetic variation | Q62800557 | ||
| Chromosomal Instability and Tumors Promoted by DNA Hypomethylation | Q63253103 | ||
| Epigenetic modifications and human disease | Q29619753 | ||
| Developmental Origins of Health and Disease: A Lifecourse Approach to the Prevention of Non-Communicable Diseases | Q30235339 | ||
| Effects of DNA Methylation on Progression to Interstitial Fibrosis and Tubular Atrophy in Renal Allograft Biopsies: A Multi-omics Approach | Q30252315 | ||
| Epigenetics in Kidney Transplantation: Current Evidence, Predictions, and Future Research Directions. | Q30278703 | ||
| OPTN/SRTR 2012 Annual Data Report: kidney | Q30724491 | ||
| Association between cytokine gene polymorphisms and outcomes in renal transplantation: a meta-analysis of individual patient data | Q31152423 | ||
| Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years | Q31904809 | ||
| Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus | Q33650362 | ||
| DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease | Q33740666 | ||
| From hematopoietic progenitors to B cells: mechanisms of lineage restriction and commitment | Q33787798 | ||
| Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease | Q34111804 | ||
| Diagnosis and prevention of chronic kidney allograft loss | Q34224452 | ||
| LINE-1 hypomethylation in blood and tissue samples as an epigenetic marker for cancer risk: a systematic review and meta-analysis | Q34282505 | ||
| Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation | Q34289498 | ||
| Cardiovascular epigenetics: basic concepts and results from animal and human studies | Q34537250 | ||
| Long non-coding RNAs and control of gene expression in the immune system | Q34616243 | ||
| Methylation determines fibroblast activation and fibrogenesis in the kidney | Q35019643 | ||
| Transcriptome analysis of human diabetic kidney disease | Q35180096 | ||
| Epigenetic modifications of the immune system in health and disease | Q35558450 | ||
| Methylation and demethylation in the regulation of genes, cells, and responses in the immune system | Q35571270 | ||
| DNA methylation and expression of major histocompatibility complex class I and class II transactivator genes in human developmental tumor cells and in T cell malignancies. | Q35571274 | ||
| Epigenetics in diabetic kidney disease | Q35647853 | ||
| Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy | Q35739097 | ||
| Minireview: Epigenetic programming of diabetes and obesity: animal models | Q35762684 | ||
| Demethylation of the TSDR is a marker of squamous cell carcinoma in transplant recipients | Q35834994 | ||
| Low fruit consumption and folate deficiency are associated with LINE-1 hypomethylation in women of a cancer-free population | Q35858857 | ||
| Quantitative detection of promoter hypermethylation as a biomarker of acute kidney injury during transplantation. | Q36102469 | ||
| The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation | Q36390497 | ||
| Epigenetic modifications and diabetic nephropathy. | Q36471772 | ||
| Epigenetic regulation of colon cancer and intestinal stem cells | Q36736072 | ||
| Conversion to sirolimus therapy in kidney transplant recipients with new onset diabetes mellitus after transplantation | Q36899502 | ||
| The evolution of renal transplantation in clinical practice: for better, for worse? | Q37300826 | ||
| Epigenetic control of T-helper-cell differentiation | Q37371624 | ||
| Kidney transplantation: future challenges | Q37388470 | ||
| Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells | Q37396074 | ||
| Beyond genetics: epigenetic code in chronic kidney disease | Q37402757 | ||
| Epigenetic mechanisms of regulation of Foxp3 expression | Q37412329 | ||
| Essential concept of transplant immunology for clinical practice | Q37428551 | ||
| Public health consequences of chronic kidney disease | Q37458590 | ||
| Chronic allograft nephropathy--a clinical syndrome: early detection and the potential role of proliferation signal inhibitors | Q37589673 | ||
| Epigenetic events during B lymphocyte development. | Q37624372 | ||
| DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study | Q37668895 | ||
| Mechanisms involved in the developmental programming of adulthood disease | Q37730191 | ||
| The role of natural killer cells in human solid organ and tissue transplantation | Q37853788 | ||
| Regulatory T cell therapy for the induction of clinical organ transplantation tolerance | Q37932810 | ||
| Epigenetics: time to translate into transplantation | Q37995936 | ||
| Mechanisms of DNA methylation and demethylation in mammals | Q38013494 | ||
| Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation. | Q38027504 | ||
| Chronic renal allograft injury: early detection, accurate diagnosis and management. | Q38035660 | ||
| Epigenetic regulation of B lymphocyte differentiation, transdifferentiation, and reprogramming. | Q38045305 | ||
| The role of promoter hypermethylation in fibroblast activation and fibrogenesis | Q38055432 | ||
| T-cell memory differentiation: insights from transcriptional signatures and epigenetics. | Q38076478 | ||
| Development and maintenance of regulatory T cells | Q38092234 | ||
| Biomarkers for kidney transplant rejection | Q38180358 | ||
| Complement as a multifaceted modulator of kidney transplant injury | Q38217273 | ||
| The effect of ischemia/reperfusion on the kidney graft | Q38218153 | ||
| Ischemic epigenetics and the transplanted kidney | Q38306439 | ||
| Cancer incidence before and after kidney transplantation | Q38464934 | ||
| Ischaemia-reperfusion injury: a major protagonist in kidney transplantation | Q39295523 | ||
| Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development | Q39338522 | ||
| Methylated genes as potential biomarkers in prostate cancer | Q39910571 | ||
| LINE-1 hypermethylation in white blood cell DNA is associated with high-grade cervical intraepithelial neoplasia. | Q40064607 | ||
| Histone deacetylase inhibitors suppress natural killer cell cytolytic activity | Q40161252 | ||
| Clinical potential of DNA methylation in organ transplantation. | Q40711439 | ||
| FTO modulates circadian rhythms and inhibits the CLOCK-BMAL1-induced transcription | Q41101772 | ||
| Pre-B cell to macrophage transdifferentiation without significant promoter DNA methylation changes | Q42587665 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| DNA methylation | Q874745 | ||
| P304 | page(s) | 1602539 | |
| P577 | publication date | 2019-01-15 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Unveiling the Role of DNA Methylation in Kidney Transplantation: Novel Perspectives toward Biomarker Identification | |
| P478 | volume | 2019 |
| Q92508960 | Dietary Patterns are Associated with Leukocyte LINE-1 Methylation in Women: A Cross-Sectional Study in Southern Italy | cites work | P2860 |
Search more.